Results 31 to 40 of about 267,969 (148)

The Venom Repertoire of Conus gloriamaris (Chemnitz, 1777), the Glory of the Sea

open access: yesMarine Drugs, 2017
The marine cone snail Conus gloriamaris is an iconic species. For over two centuries, its shell was one of the most prized and valuable natural history objects in the world.
Samuel D. Robinson   +6 more
doaj   +1 more source

Fish-hunting cone snail venoms are a rich source of minimized ligands of the vertebrate insulin receptor

open access: yeseLife, 2019
The fish-hunting marine cone snail Conus geographus uses a specialized venom insulin to induce hypoglycemic shock in its prey. We recently showed that this venom insulin, Con-Ins G1, has unique characteristics relevant to the design of new insulin ...
Peter Ahorukomeye   +13 more
doaj   +1 more source

High-throughput prediction and characterization of antimicrobial peptides from multi-omics datasets of Chinese tubular cone snail (Conus betulinus)

open access: yesFrontiers in Marine Science, 2022
Individual cone snail (Conus sp.) contains thousands of bioactive peptides, but there are limited studies on its antimicrobial peptides (AMPs). Here, we investigated AMPs along with AMP-derived genes in the representative Chinese tubular cone snail (C ...
Ruihan Li   +16 more
doaj   +1 more source

Clinical effectiveness of hymenoptera venom immunotherapy [PDF]

open access: yes, 2013
Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Our aim was to evaluate the association of baseline serum tryptase concentration (BTC) and of other parameters with the frequency of VIT failure during ...
Scheipl, Fabian   +21 more
core   +1 more source

Toxinology of Marine Venomous Snails

open access: yesIranian South Medical Journal, 2021
A surprisingly large number of sea snail species are venomous. Cone snail venoms are produced in a lengthy tubular duct from a complex venom gland and form a cocktail of many toxins, particularly conotoxins which have high potency and specificity for ...
Gholam Hossein Mohebbi, Iraj Nabipour
doaj  

In the picture: disulfide-poor conopeptides, a class of pharmacologically interesting compounds

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2016
During evolution, nature has embraced different strategies for species to survive. One strategy, applied by predators as diverse as snakes, scorpions, sea anemones and cone snails, is using venom to immobilize or kill a prey.
Eline K. M. Lebbe, Jan Tytgat
doaj   +1 more source

Small Molecules in the Cone Snail Arsenal

open access: yes, 2015
Cone snails are renowned for producing peptide-based venom, containing conopeptides and conotoxins, to capture their prey. A novel small-molecule guanine derivative with unprecedented features, genuanine, was isolated from the venom of two cone snail ...
Vitor Vasconcelos (108651)   +6 more
core   +1 more source

Pharmacological aspects of Vipera xantina palestinae venom [PDF]

open access: yes, 2011
In Israel, Vipera xantina palestinae (V.x.p.) is the most common venomous snake, accounting for several hundred cases of envenomation in humans and domestic animals every year, with a mortality rate of 0.5 to 2%.
Katzhendler, Jeoshua   +14 more
core   +1 more source

The sobering sting: A novel cone snail venom-derived antagonist of cannabinoid receptors counteracts learning and memory deficits - SI File

open access: yes, 2023
This item is supplemental material for the article entitled "The sobering sting: A novel cone snail venom-derived antagonist of cannabinoid receptors counteracts learning and memory deficits".
Guilherme Carrazoni (10488218)
core   +1 more source

Selective modulation of NaV channel gating counteracts aberrant hyperexcitability and rescues motor function and survival in a model of spinal muscular atrophy

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Spinal muscular atrophy (SMA) is a motor neuron disease caused by SMN1 gene loss, leading to reduced survival motor neuron (SMN) protein and progressive motor neuron degeneration. Although SMN‐restoring therapies improve outcomes, residual disease burden and non‐curative efficacy underscore the need for complementary treatments ...
Fernanda C. Cardoso   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy